Roger J. Pomerantz

Roger J. Pomerantz, MD, FACP, serves as Vice Chairman of the Board at Enlivex Therapeutics and holds various leadership roles including Founding Chairman of the Board at Indaptus Therapeutics, Chairman of the Board at Viracta Therapeutics and CollPlant, and Senior Clinical Advisor at Seres Therapeutics. Pomerantz has made significant contributions in the biotech field, having previously served as President, CEO, and Chairman of ContraFect Corp., alongside positions in multiple consulting and advisory roles. Educational achievements include a medical degree from The Johns Hopkins University, a postdoctoral fellowship at MIT focusing on molecular virology, and extensive clinical training at Harvard Medical School and Massachusetts General Hospital.